Loading…
SNY
Sanofi
NASDAQ· Healthcare· Drug Manufacturers - General· CUSIP 80105N105
$41.96+2.42%Price as of Oct 23, 00:46 UTC · updated once a day, after the close
At a glance
Sanofi (SNY) is listed on NASDAQ and classified in Drug Manufacturers - General, part of the Healthcare sector. It is headquartered in Paris, France and has 74,846 employees. The company is worth $100.54B and trades at 22.1x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was €46.72B in fiscal 2025, up 5.5% from the year before. Net income was €7.81B. The share price is 20.3% below its 52-week high of $52.68. It pays a dividend yielding 5.77%. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Israel Englander (Millennium Management), at $159.03M. In that quarter, 6 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $100.54B
- P/E
- 22.1x
- Forward P/E
- 7.9x
- P/B
- 1.3x
- Dividend yield
- 5.77%
- Payout
- 127.37%
- EPS
- $1.90
- ROE
- 5.71%
- Profit margin
- 8.09%
- Revenue growth
- +14.60%
- Beta
- 0.28
- 52-week high
- $52.68
- 52-week low
- $39.07
History
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in EUR, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -14.6% over 5Y.
today you would have $997.79▼ -0.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $48.46 | $48.23 | $49.73 | $48.43 | |
| EPS | €3.19 | €2.30 | €2.16 | €2.69 | |
| Dividend yield | 4.22% | 4.56% | 4.22% | 3.83% | 4.22% |
| Profit margin | 14.85% | 16.72% | 12.55% | 12.98% | 20.64% |
| ROE | 9.12% | 10.95% | 7.17% |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
$37.24
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
Earnings
$10.96
Earnings growing 0.0% a year plus a 5.8% dividend yield. Growth capped at 25%.
Earnings
$46.14
Median P/E of 24.3 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
$155.58
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| HCAHCA Healthcare, Inc. | $467.31 | 15.4x | — | 0.67% | — | $101.17B |
| GSKGSK plc | $51.21 | 15.8x | 4.3x | 3.55% | 33.38% | $102.6B |
| ELVElevance Health, Inc. | $445.28 | 18.4x | 2.2x | 1.55% | 11.13% | $96.57B |
| SYKStryker Corp | $307.08 |
About the company
- 74,846
- Paris, France
